Brooks Laboratories Ltd

BROOKS
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹227 cr, stock is ranked 1,650
High RiskStock is 3.91x as volatile as Nifty
88.104.00 (-4.34%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹227 cr, stock is ranked 1,650
High RiskStock is 3.91x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-11.75
PB RatioPB Ratio
2.87
Dividend YieldDiv. Yield
Sector PESector PE
32.23
Sector PBSector PB
4.77
Sector Div YldSctr Div Yld
0.86%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Brooks Laboratories Ltd. is a Contract Manufacturing Company. The Company manufacturers molecules in Injectables and Clavulanic Acid range in Tablets and Dry Syrups.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202155.9557.9170.1077.99-13.82-14.80-24.37-19.36
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Disclosure of other UPSI/material event 
Announced OnMay 23, 2022

Brooks Laboratories Limited has informed the Exchange about Disclosure of other UPSI/material event | Download

Brooks Laboratories Limited has informed the Exchange about Disclosure of other UPSI/material event | Download

General updates 
Announced OnMay 10, 2022

Brooks Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI(LODR), Regulations, 2015 | Download

Brooks Laboratories Limited has informed the Exchange about Disclosure under Regulation 30 of SEBI(LODR), Regulations, 2015 | Download

Price movement 
Announced OnApr 11, 2022

BROOKS : Significant movement in price has been observed in Brooks Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Brooks Laboratories Limited has submitted their response. | Download

BROOKS : Significant movement in price has been observed in Brooks Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Brooks Laboratories Limited has submitted their response. | Download

See all events